- Company Overview for PALLA PHARMA (UK) HOLDING LIMITED (12500847)
- Filing history for PALLA PHARMA (UK) HOLDING LIMITED (12500847)
- People for PALLA PHARMA (UK) HOLDING LIMITED (12500847)
- More for PALLA PHARMA (UK) HOLDING LIMITED (12500847)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
15 Mar 2024 | CS01 | Confirmation statement made on 4 March 2024 with updates | |
14 Sep 2023 | PSC08 | Notification of a person with significant control statement | |
14 Sep 2023 | PSC07 | Cessation of Morten Andresen as a person with significant control on 30 August 2023 | |
12 Sep 2023 | AA | Total exemption full accounts made up to 31 December 2022 | |
06 Apr 2023 | PSC01 | Notification of Morten Andresen as a person with significant control on 21 December 2022 | |
06 Apr 2023 | PSC09 | Withdrawal of a person with significant control statement on 6 April 2023 | |
08 Mar 2023 | CS01 | Confirmation statement made on 4 March 2023 with updates | |
06 Mar 2023 | AA | Total exemption full accounts made up to 31 December 2021 | |
15 Feb 2023 | TM01 | Termination of appointment of Richard Scullion as a director on 27 January 2023 | |
15 Feb 2023 | AP01 | Appointment of Karin Bjune Sveen as a director on 27 January 2023 | |
16 Mar 2022 | CS01 | Confirmation statement made on 4 March 2022 with no updates | |
12 Oct 2021 | AA | Accounts for a dormant company made up to 31 December 2020 | |
22 Apr 2021 | CS01 | Confirmation statement made on 4 March 2021 with no updates | |
05 Mar 2021 | TM01 | Termination of appointment of Jarrod Ritchie as a director on 22 December 2020 | |
26 Mar 2020 | AP01 | Appointment of Richard Scullion as a director on 26 March 2020 | |
05 Mar 2020 | AA01 | Current accounting period shortened from 31 March 2021 to 31 December 2020 | |
05 Mar 2020 | NEWINC |
Incorporation
Statement of capital on 2020-03-05
|